首页|孟鲁司特钠联合丙酸氟替卡松鼻喷雾剂治疗儿童过敏性鼻炎的效果

孟鲁司特钠联合丙酸氟替卡松鼻喷雾剂治疗儿童过敏性鼻炎的效果

扫码查看
目的 探讨孟鲁司特钠联合丙酸氟替卡松鼻喷雾剂治疗儿童过敏性鼻炎(anaphylactic rhinitis,AR)的效果。方法 选取AR患儿100例作为研究对象,用1∶1简单随机法分为观察组和对照组,每组50例。对照组予以丙酸氟替卡松鼻喷雾剂治疗,观察组在对照组治疗的基础上联合孟鲁司特钠治疗。2组患儿均持续治疗8周。评估患儿鼻痒、打喷嚏、鼻塞和流涕等临床症状积分,并观察中文版鼻腔鼻窦结局测试量表(sino-nasal outcome test-20,SNOT-20)评分变化;检测患儿鼻通气功能[动脉鼻气道阻力(nasal airway resistance,NAR)、0~5 cm鼻腔容积(nasal cavity volume,NCV)、鼻腔最小横截面积(nasal minimal cross-sectional area,NMCA)和鼻呼吸量(nasal spirometry,NS)]及炎症因子[血降钙素原(procalcitonin,PCT)、白细胞介素(interleukin,IL)-1β和IL-6]水平;比较2组不良反应的发生率。结果 观察组患儿的临床总有效率(96。00%)高于对照组(84。00%),P<0。05;2组患儿临床症状(鼻痒、鼻塞、打喷嚏和流涕)及SNOT-20评分均降低,且观察组均低于对照组(P<0。05);治疗后观察组NAR明显低于对照组,NCV、NMCA和NS显著高于对照组(P<0。05);治疗后观察组患儿的PCT、IL-1β和IL-6水平明显低于对照组(P<0。05);2组不良反应发生率比较差异无统计学意义(P>0。05)。结论 孟鲁司特钠联合丙酸氟替卡松鼻喷雾剂治疗AR有利于提高患儿的临床疗效,可改善患儿鼻通气功能和临床症状,降低炎症反应,提高生活质量。
Curative effect of montelukast sodium combined with Fluticasone Propionate Nasal Spray in children with allergic rhinitis
Objective To explore the curative effect of montelukast sodium combined with Fluticasone Propionate Nasal Spray in children with allergic rhinitis(AR).Methods A total of 100 children with AR were enrolled as the research objects.According to simple randomization method,they were divided into observation group(n=50)and control group(n=50).The control group was treated with Fluticasone Propionate Nasal Spray,while the observation group was additionally treated with montelukast sodium.All were treated continuously for 8 weeks.The scores of clinical symptoms(nasal itching,sneezing,nasal congestion,and runny nose)were evaluated.The changes in scores of sinonasal outcome test scales-20(SNOT-20)were observed.The nasal ventilation function[nasal airway resistance(NAR),0-5 cm nasal cavity volume(NCV),nasal minimal cross-sectional area(NMCA),and nasal spirometry(NS)]and inflammatory factors[procalcitonin(PCT),and interleukin(IL)-1β,IL-6]were detected.The incidence of adverse reactions in the 2 groups was compared.Results The clinical total response rate of observation group was higher than that of control group(96.00%vs.84.00%,P<0.05).After treatment,the scores of clinical symptoms(nasal itching,nasal congestion,sneezing,runny nose)and SNOT-20 in both groups were decreased,which were lower in observation group than in control group(P<0.05).After treatment,NAR in observation group was significantly lower than that in control group,while the NCV,NMCA and NS were significantly higher than those in control group(P<0.05).After treatment,the levels of PCT,IL-1β and IL-6 in observation group were significantly lower than those in control group(P<0.05).The difference in the incidence of adverse reactions between the 2 groups was not statistically significant(P>0.05).Conclusion Montelukast sodium combined with Fluticasone Propionate Nasal Spray is beneficial to improve clinical curative effect,nasal ventilation function and clinical symptoms,reduce inflammatory response and improve the quality of life in children with AR.

montelukast sodiumFluticasone Propionate Nasal Sprayallergic rhinitisnasal ventilation functionserum procalcitonininterleukin-1βinterleukin-6

李慧、聂雷、张佩瑶、刘煜、高士培

展开 >

首都医科大学附属北京儿童医院保定医院耳鼻喉科,保定 071000

首都医科大学附属北京儿童医院保定医院口腔科,保定 071000

孟鲁司特钠 丙酸氟替卡松鼻喷雾剂 过敏性鼻炎 鼻通气功能 血降钙素原 白细胞介素-1β 白细胞介素-6

保定市科技计划项目

2041ZF135

2024

西北药学杂志
西安交通大学,陕西省药学会

西北药学杂志

CSTPCD
影响因子:0.912
ISSN:1004-2407
年,卷(期):2024.39(3)
  • 20